Coronary arteries – anatomy and diseases

Introduction The coronary arteries, popularly known as coronary arteries, supply the heart with oxygen-rich blood. Immediately after the aortic valve, the two main branches of the coronary arteries emerge from the ascending part of the aorta. The left coronary artery mainly supplies the anterior wall of the heart and the right coronary artery supplies the … Coronary arteries – anatomy and diseases

Diseases of the coronary arteries | Coronary arteries – anatomy and diseases

Diseases of the coronary arteries A major cause of coronary artery disease is coronary artery disease (CHD), which leads to an insufficient oxygen supply to the heart muscle tissue. Under physical exertion the oxygen demand of the heart muscle increases. In a healthy person, the coronary arteries would dilate so that more oxygen-rich arterial blood … Diseases of the coronary arteries | Coronary arteries – anatomy and diseases

Detoxification

Definition Detoxification is the process of removing or removing and metabolising substances that are harmful to the body. A detox can either be initiated or carried out by the body itself, e.g. when the amount of harmful substances exceeds a certain level, or it can be induced from the outside by the administration of drugs … Detoxification

Pentalong®

Active ingredient: pentaerythrityl tetranitrateThe active ingredient belongs to the group of vasodilating substances (nitrates) and is used to promote blood flow to the heart in the case of constricted coronary arteries. In the organism, the active ingredient is broken down into the body’s own nitrogen monoxide (NO). This has a direct dilating effect on the … Pentalong®

Interactions | Pentalong®

Interactions When taking other medications in addition to Pentalong®, it must be noted that the effect of the medication may be intensified. This applies, for example, to the simultaneous intake of beta blockers, calcium channel blockers, diuretics, ACE inhibitors, phosphodiesterase inhibitors, certain antidepressants and neuroleptics, as well as alcohol consumption. Pentalong® also weakens the effect … Interactions | Pentalong®

Background | Pentalong®

Background Pentalong® was developed in the USA in the 1950s. Since 1964 it was produced in the former GDR by a Zwickau company. Today the company Actavis holds the rights to Pentalong®. However, since the drug never had to go through an approval procedure, Actavis had to apply for a subsequent approval. This was the … Background | Pentalong®

Sports | Circulatory disorder in the heart

Sports Sport has two important functions in relation to circulatory disorders. Physical activity and exercise is an important preventive measure and can promote oxygen supply and the formation of circulatory bypasses, especially in the case of arterial occlusive diseases. In addition, sport helps to reduce overweight and is often accompanied by a healthy diet. This … Sports | Circulatory disorder in the heart

PTCA: Procedure of the Examination

Before the actual procedure, several preliminary tests are needed to assess the number, extent, and location of the narrowings, as well as risk factors. These include ECG and exercise ECG, blood tests, and a chest x-ray to evaluate the heart and lungs. Special attention is paid to the question of an existing allergy, hyperthyroidism or … PTCA: Procedure of the Examination